European Association for the Study of the Liver

EASL Podcasts

Health EN ↓ 168 episodes

The EASL Podcast collection brings together Talk Liver to Me , EASL’s exclusive original podcast, alongside educational audio content adapted from EASL Studio, DeepDive webinars, and Policy Dialogues. Stay informed with expert insights, practical discussions, and the latest knowledge in hepatology — anytime, anywhere.

Be sure to visit the podcast's website and support the creator: easl-podcasts.buzzsprout.com

Author

European Association for the Study of the Liver

Category

Health

Latest episode

Nov 11, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Talk Liver To Me - Cholangiocarcinoma surveillance in PSC: What should we do now and what’s coming next? 11.11.2026

Discover how clinicians are approaching screening and surveillance in PSC today. From imaging and endoscopy to the promise of new biomarkers, this episode highlights key tools, ongoing challenges, and future directions in improving early detection of cholangiocarcinoma.  Host:   Debbie Shawcross (King's College London) Guests:   Jesús Bañales (Donostia University Hospital), Gideon Hirschfield...

EASL DeepDive: AI-Enabled Clinical Trials: Opportunities, Evidence and Oversight 09.11.2026

Artificial intelligence (AI) is opening new opportunities to improve the design, efficiency, and evidence generation of clinical trials. This EASL DeepDive examines its applications in patient selection, stratification, and trial workflows, as well as the emerging role of digital twins in simulating treatment responses. Particular attention is given to the use of AI-enabled real-world data to stre...

Talk Liver To Me - Hepatocellular Carcinoma: Who to screen, when, and how? 28.10.2026

Hepatocellular carcinoma (HCC) surveillance is a cornerstone of liver disease management, yet uncertainty persists around who to screen, when to initiate surveillance, and which modalities to use. Evolving risk profiles and variation across guidelines have added complexity to clinical decision-making. In this podcast, we revisit the fundamentals of HCC screening, focusing on practical, evidence-ba...

Talk Liver To Me - Psychohepatology: Are we overlooking mental health in liver disease care? 14.10.2026

This episode explores psychohepatology, examining the gut–liver–brain axis and the bidirectional links between liver disease and mental health. Discussion covers addiction biology, the impact of trauma and post-traumatic stress disorder (PTSD) on alcohol use, and the high prevalence of depression and anxiety in cirrhosis, highlighting integrated approaches to liver and mental health care.  Host: M...

EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma 09.10.2026

This EASL Deep Dive explores key updates from the EASL Clinical Practice Guidelines on hepatocellular carcinoma (HCC), with a practical focus on diagnosis and treatment selection. Experts will discuss evolving imaging and diagnostic criteria, patient selection for surgery and locoregional therapies, and how to adapt management according to response to systemic treatment. The session will also high...

Resmetirom and Semaglutide in MASH: Who, when and how to monitor? 30.09.2026

This episode of Talk Liver to Me explores the practical use of resmetirom and semaglutide in MASH, based on the 2026 EASL–EASD–EASO Guidance. Experts discuss who may benefit from treatment, when to initiate therapy, and how to monitor response and efficacy in clinical practice.  Host:   Debbie Shawcross (EASL) Guests:   Andreea Ciudin (EASO), Amalia Gastaldelli (EASD), Frank Tacke (EASL)  This epi...

Talk Liver To Me - Africa’s Liver Crisis: Why Is No One Talking About It? 16.09.2026

Liver disease represents a major and under-recognised public health challenge across Africa, driven by a complex interplay of viral hepatitis, rising metabolic dysfunction-associated steatotic liver disease, and a high burden of hepatocellular carcinoma (HCC). Despite this, awareness, surveillance, and access to care remain limited. In this podcast, we explore the evolving epidemiology of liver di...

EASL DeepDive: Utility and challenges of genetic testing in PFIC 14.09.2026

This webinar explores the role of genetic testing in diagnosing Progressive Familial Intrahepatic Cholestasis (PFIC). Attendees will review key test types, understand the principles behind modern genomic technologies, and learn how to position these tests in the diagnostic approach of a person with a suspicion of PFIC and how to navigate common challenges in interpreting genetic results. The sessi...

Talk Liver To Me - What are the Dos and Don'ts in Acute Liver Failure? 02.09.2026

Acute liver failure (ALF) is a rare but life-threatening condition requiring rapid recognition and decisive management. Early decisions around investigation, escalation, and referral can significantly impact outcomes. Despite advances in care, variation in practice and avoidable pitfalls remain common. In this podcast, we take a practical, case-based approach to the key “dos and don’ts” in ALF man...

Talk Liver To Me - Endohepatology: Added value or added complexity? 19.08.2026

Endohepatology is emerging as a novel approach to liver disease assessment, with the potential to combine EUS-guided liver biopsy, portal pressure measurement, and variceal evaluation within a single session. This “one-stop shop” model could streamline diagnostic pathways and enable integrated, real-time clinical decision-making. However, this innovation comes at a time when hepatology is moving i...

Talk Liver To Me - What nobody tells you about starting a research group 05.08.2026

Early-career researchers and clinician-scientists play a central role in advancing hepatology research and innovation, yet the transition to independence often comes with challenges that extend beyond scientific expertise. Building a research programme, leading teams, securing funding, and developing a sustainable academic career require skills that are rarely addressed during formal training. In...

Talk Liver To Me - Global Updates on Hepatitis E: How Should We Manage Acute and Chronic Infection? 22.07.2026

Hepatitis E is a globally prevalent infection with diverse clinical manifestations, ranging from self-limiting acute hepatitis to chronic infection in immunosuppressed patients. Its presentation and epidemiology vary significantly between regions, influencing diagnostic and management strategies. Despite increasing recognition, uncertainty remains around who to test, when to treat, and how to mana...

Talk Liver To Me - MASLD and HFpEF: Do We Need a Shared Treatment Strategy? 08.07.2026

Metabolic dysfunction-associated steatotic liver disease (MASLD) and heart failure with preserved ejection fraction (HFpEF) are increasingly recognised as manifestations of a shared cardiometabolic disorder. Driven by overlapping risk factors such as obesity and insulin resistance, these conditions frequently coexist and may interact through liver–heart crosstalk. Despite this, they are typically...

A joint EASL-ERN RARE-LIVER DeepDive – Wilson’s disease: a 2026 update 03.07.2026

The following objectives will be addressed in this EASL Deep Dive episode: Have a profound knowledge of the pitfalls, limitations and difficulty of interpretation of the different tests of copper metabolism and liver copper assessments Be able to establish a diagnostic approach to Wilson’s disease, integrating clinical, laboratory, genetic and imaging tools Have a good understanding of the differe...

Talk Liver To Me - Chasing the perfect SLD preclinical model 24.06.2026

Steatotic liver disease (SLD) research relies heavily on preclinical models, yet no single model can fully capture the complexity of human disease. In this episode, we explore the new EASL position paper on preclinical SLD models. From MASLD and MetALD to organoids and precision-cut liver slices, we discuss the strengths, limitations, and translational relevance of today's most widely used mo...

Talk Liver To Me - Haemochromatosis in 2026: Who Needs Testing and Who Needs Treatment? 10.06.2026

Haemochromatosis remains one of the most common inherited metabolic disorders, yet it is frequently underdiagnosed and inconsistently managed in clinical practice. With widespread use of iron studies and genetic testing, clinicians are increasingly faced with questions around interpretation, penetrance, and clinical significance. In this podcast, we explore current challenges in diagnosis and mana...

Talk Liver To Me - Liver Transplantation: Rise of the machines 13.05.2026

In this episode, we discuss the first pig-to-human liver xenotransplantation and the breakthroughs behind the revival of xenotransplantation, examining its potential and remaining challenges. We also explore the accelerating field of machine perfusion, clarifying different approaches and reviewing the evidence supporting their role in organ assessment, optimisation, and DCD utilisation. Host: Sarw...

Talk Liver To Me - Spontaneous Bacterial Peritonitis: Time to Rethink the Rules? 29.04.2026

Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis - but rising antimicrobial resistance and emerging data are challenging long-standing practices. In this episode, we review current evidence on primary and secondary prophylaxis, resistance patterns, albumin use, and treatment strategies. How should clinicians balance prevention with antimicrobial stewardship? And wh...

EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on extrahepatic Cholangiocarcinoma (eCCA) 23.04.2026

In this EASL DeepDive webinar, the expert panel presents and explains the key studies behind the latest recommendations included in the EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma. Learning Objectives To identify patients at risk for eCCA, and review the current tools and strategies for its surveillance, diagnosis, staging, and classification To define th...

Talk Liver To Me - World Liver Day: Making Lifestyle Change Possible 15.04.2026

This episode explores the role of lifestyle in preventing and managing liver disease, including MASLD/MASH. Our experts discuss the impact of diet and physical activity, why lifestyle change can be difficult to start and sustain, and why small, achievable steps can still make a meaningful difference.  Host: Cyrielle Caussy Speakers:   Kate Hallsworth and Manuel Romero-Gómez  This episode is also a...

EASL DeepDive: The Pursuit of a Cure: HCC Management Strategies 09.04.2026

Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are diagnosed at an advanced stage, making curative treatment difficult. In this DeepDive Webinar, you’ll be guided through the latest advances in hepatocellular carcinoma management, from the r...

EASL DeepDive: EASL Clinical Practice Guidelines on the management of autoimmune hepatitis 09.04.2026

In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of autoimmune hepatitis, published in the "Journal of Hepatology" in 2025. Learning objectives Select induction and maintenance treatment strategies aimed at achieving complete biochemical response Recognise and manage disease flares, treatment intolerance, and subop...

EASL DeepDive: Key Changes in the New EASL HBV Guidelines 09.04.2026

In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of hepatitis B virus infection, published in the "Journal of Hepatology" in 2025. Learning objectives Understand the updated EASL recommendations for initiating and discontinuing antiviral therapy in chronic hepatitis B, including key differences with other HBV guide...

Talk Liver To Me - Baveno VIII: The takeaways you shouldn’t miss 01.04.2026

In this episode our speakers share their immediate impressions and break down the key highlights shaping the management of portal hypertension and advanced liver disease. What has truly changed in practice? Where was consensus reached and where do controversies remain? Tune in for a clear, practical overview of what you need to know from Baveno VIII. Host: Thomas Marjot Speakers:   Mattias Mandorf...

Talk Liver To Me - Updated BCLC Guidelines for HCC: Protocolised or Patient-Centred Care? 18.03.2026

This episode unpacks the updated BCLC guidelines for hepatocellular carcinoma management. Experts discuss the strengths and limitations of the BCLC model in an era of rapidly evolving systemic therapies and personalised care, sharing real-world examples of when the algorithm helps and when clinical practice diverges. Host: Mattias Mandorfer Speakers:   Marco Sanduzzi, Lorenza Rimassa This episode...

Listen to the EASL Podcasts podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.